K. Z. Abbas, Department of Thoracic Medicine and Surgery, Temple University Hospital, Philadelphia, USA
T. Caton and P. Rali

direcct link
https://www.ncbi.nlm.nih.gov/pubmed/42309631

Heart Fail Clin 2026 Vol. 22 Issue 3 Pages 387-397

Pulmonary embolism (PE) is associated with substantial long-term morbidity that extends past initial diagnosis. Patients diagnosed with PE face risks of chronic thromboembolic pulmonary hypertension, post-PE syndrome, recurrent venous thromboembolism, psychological distress, and impaired quality of life. Optimal follow-up is critical for early recognition and intervention. This article synthesizes contemporary evidence, including guideline recommendations, registry data, and recent clinical studies. The aim of this article is to outline a structured approach to PE follow-up, addressing who should be monitored, when, and with which modalities.